What is ANGX's warrants issued?

ANGX (ANGX) reported warrants issued of $227.85K in Q1 2026.

How has ANGX's warrants issued changed year-over-year?

ANGX's warrants issued decreased by 64.0% year-over-year, from $633.27K to $227.85K.

What does warrants issued mean?

Reflects the issuance of warrants, which are financial instruments granting the holder the right to purchase company stock at a specified price. This is a non-cash financing activity that represents potential future dilution for existing shareholders.

ANGX ANGX Warrants Issued

Warrants Issued at other companies

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Taysha Gene Therapies, Inc.TSHA

$56.25K—

CytomX TherapeuticsCTMX

$5.86M—

NovaGold ResourcesNG

$9.9M—

Monte Rosa Therapeutics, Inc.GLUE

$0-100%

ADMA BiologicsADMA

$1.4M—

Other financials

Income statement

See full

Revenue$115.1M+143%

Gross profit$71.1M+154%

Operating income-$2.7M+92.1%

Net income-$13.8M+63.0%

EPS (diluted)-$0.08+68.0%

Balance sheet

See full

Cash & equivalents$38.9M+10,871%

Total debt$64.8M—

Total equity-$10.2M-184%

Total assets$213.1M+20,635%

Cash flow

See full

Operating cash flow$1.9M+119%

Valuation

See full

Market cap$546.03M-74.4%

Enterprise value$571.99M—

P/S1.4×—

Profitability

See full

Gross margin61.6%—

Operating margin-28.8%—

Net margin-34.1%—

Returns & leverage

See full

Current ratio0.6×+0.5×

Where this comes from

Reported directly by ANGX in its filing.

Tagged under the XBRL concept angel:WarrantsIssued.

The official record: ANGX’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANGX's warrants issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANGX's warrants issued?: ANGX (ANGX) reported warrants issued of $227.85K in Q1 2026.
How has ANGX's warrants issued changed year-over-year?: ANGX's warrants issued decreased by 64.0% year-over-year, from $633.27K to $227.85K.
What does warrants issued mean?: Reflects the issuance of warrants, which are financial instruments granting the holder the right to purchase company stock at a specified price. This is a non-cash financing activity that represents potential future dilution for existing shareholders.